Pharmacotherapy of major depressive disorder in adolescents

Expert Opinion on Pharmacotherapy
Gabriele MasiPaola Brovedani

Abstract

At any one time, major depressive disorder (MDD) affects 4 - 6% of adolescents. When untreated, MDD leads to a high immediate and subsequent suicide risk, long-term chronicity and a poor psychosocial outcome. Whereas psychotherapy can be effective in mild depression, it seems to be less effective in moderate and severe depression. However, although the use of antidepressants increased markedly during the 1990s, in recent years it has decreased as a result of concerns regarding the emergence of suicidality during antidepressant treatment. Are antidepressants truly effective? What is the relationship between different treatments for depression - psychotherapy and pharmacotherapy - alone or in combination? Can antidepressants increase the risk of suicide in some adolescents? Can antidepressants reduce suicide risk in suicidal adolescents? There is evidence that selective serotonin reuptake inhibitors (SSRIs) can improve adolescent depression better than placebo, although the magnitude of the antidepressant effect is 'small to moderate', because of a high placebo response. The SSRI with the best rate of response compared to placebo is fluoxetine. The increased risk of suicidality in adolescents, compared to adults, is weak but cons...Continue Reading

References

Jan 1, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·M StroberR Diamond
Nov 11, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·J RenaudJ Bridge
May 18, 1999·JAMA : the Journal of the American Medical Association·M M WeissmanP Wickramaratne
Jan 13, 2000·Archives of General Psychiatry·B BirmaherR E Ulloa
Jan 4, 2001·The American Journal of Psychiatry·B GellerJ L Craney
Jul 5, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·M B KellerJ P McCafferty
Sep 5, 2001·The British Journal of Psychiatry : the Journal of Mental Science·E FombonneM Rutter
Oct 5, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Graham J EmslieJennie G Jacobson
Jan 15, 2003·The Journal of School Health·UNKNOWN Office on Smoking and Health, Division of Adolescent and School Health National Center for Chronic Disease Prevention and He
Aug 28, 2003·JAMA : the Journal of the American Medical Association·Karen Dineen WagnerUNKNOWN Sertraline Pediatric Depression Study Group
Oct 15, 2003·Archives of General Psychiatry·Mark OlfsonTed Greenberg
Nov 5, 2003·The American Journal of Psychiatry·Daniel A GellerStephen V Faraone
Jun 1, 2004·The American Journal of Psychiatry·Karen Dineen WagnerWilliam E Heydorn
Jun 9, 2004·Archives of General Psychiatry·Laura MufsonMyrna M Weissman
Jul 22, 2004·JAMA : the Journal of the American Medical Association·Hershel JickSusan S Jick
Jul 22, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Scott N ComptonJohn Curry
Aug 4, 2004·Archives of Pediatrics & Adolescent Medicine·Andrés MartinDouglas Leslie
Aug 19, 2004·JAMA : the Journal of the American Medical Association·John MarchUNKNOWN Treatment for Adolescents With Depression Study (TADS) Team
May 26, 2005·JAMA : the Journal of the American Medical Association·Ronald C KesslerPhilip S Wang
Sep 15, 2005·Suicide & Life-threatening Behavior·Emma EvansJonathan Deeks
Nov 22, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Tamar D WohlfarthJitschak G Storosum
Dec 6, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·E Jane CostelloAdrian Angold
Jan 27, 2006·Psychological Bulletin·John R WeiszSylvia M Valeri
Mar 8, 2006·Archives of General Psychiatry·Tarek A HammadJudith Racoosin
Mar 17, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Karen Dineen WagnerKhalil Saikali
Mar 24, 2006·Journal of Child and Adolescent Psychopharmacology·Ray BerardChristel Wilkinson
May 17, 2006·Journal of Clinical Psychopharmacology·Anne-Liis von KnorringAgnes Hultén
May 25, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Graham J EmslieChristel Wilkinson
Aug 9, 2006·Archives of General Psychiatry·Mark OlfsonDavid Shaffer
Sep 6, 2006·Child and Adolescent Psychiatric Clinics of North America·V Robin Weersing, David A Brent
Sep 30, 2006·American Journal of Public Health·Robert E McKeownRichard M Schulz
Dec 1, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Betsy KennardUNKNOWN TADS Team
Dec 1, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Christopher KratochvilUNKNOWN TADS Team
Dec 1, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Benedetto VitielloUNKNOWN TADS Team
Dec 1, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·John CurryUNKNOWN TADS Team
Dec 1, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Graham EmslieUNKNOWN TADS Team
Apr 11, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Graham J EmslieYunfeng Li
Jul 4, 2007·The American Journal of Psychiatry·Gregory E Simon, James Savarino
Jul 21, 2007·BMJ : British Medical Journal·Philip Hazell

❮ Previous
Next ❯

Citations

Dec 16, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Juan Undurraga, Ross J Baldessarini
Sep 18, 2013·Journal of Child and Adolescent Psychopharmacology·Robert L FindlingAnjana Bose
Jan 1, 2011·BMJ Case Reports·Abdul Majid WaniNajah R Zayyani
Oct 30, 2012·The Primary Care Companion to CNS Disorders·Raimo K R SalokangasJyrki Korkeila
Aug 30, 2010·Pharmaceuticals·Maurizio PompiliDavid Lester
Oct 5, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·J D A OlivierJ R Homberg
Nov 29, 2011·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Erika E Forbes, Ronald E Dahl
Nov 15, 2012·Journal of Forensic Sciences·Claudio Terranova, Daniela Sartore
Nov 22, 2016·Nutritional Neuroscience·M Atif Raza CheemaDarakhshan J Haleem
Sep 16, 2015·PLoS Medicine·Yasmina MoleroSeena Fazel
Nov 7, 2018·The Mental Health Clinician·Sandra Mullen
Dec 1, 2011·Acta Neuropsychiatrica·Raffaella CalatiGiovanni De Girolamo
Aug 22, 2020·Physiology & Behavior·Martin ReuterThomas Plieger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Child and Adolescent Psychiatric Nursing : Official Publication of the Association of Child and Adolescent Psychiatric Nurses, Inc
Mellen Lovrin
Journal of Pediatric Gastroenterology and Nutrition
Miguel Saps, Carlo Di Lorenzo
© 2021 Meta ULC. All rights reserved